Loading…
CIK 0001819257 • 6 13F filings • May 14, 2025 – Aug 12, 2026
Import this data to Google Sheets with:
=jivedata("patient-square-capital-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $17.5M | 3.8%Prev: 3.4% | 130,000 SH | Increased-21,833 SH |
| ALLOGENE THERAPEUTICS INC | COM | $6.8M | 1.5%Prev: 1.0% | 4,963,756 SH | Increased+1,982,360 SH |
| AMYLYX PHARMACEUTICALS INC | COM | $4.2M | 0.9%Prev: 1.1% | 350,000 SH | Decreased+33,688 SH |
| ARCUS BIOSCIENCES INC | COM | $4.1M | 0.9% | 170,000 SH | New |
| ARCUTIS BIOTHERAPEUTICS INC | COM | $6.1M | 1.3% | 210,000 SH | New |
| ARGENX SE | SPONSORED ADR | $21.9M | 4.7%Prev: 3.1% | 26,000 SH | Increased+10,500 SH |
| ASSEMBLY BIOSCIENCES INC | COM NEW | $4.3M | 0.9%Prev: 0.9% | 127,000 SH | Increased-8,182 SH |
| AVALO THERAPEUTICS INC | COM NEW | $5.7M | 1.2%Prev: 0.3% | 311,966 SH | Increased+211,966 SH |
| BEONE MEDICINES LTD | SPONSORED ADS | $21.1M | 4.5% | 69,312 SH | New |
| CELCUITY INC | COM | $12.0M | 2.6%Prev: 1.3% | 120,000 SH | Increased+20,000 SH |
| COGENT BIOSCIENCES INC | COM | $11.3M | 2.4% | 317,372 SH | New |
| DBV TECHNOLOGIES S A | SPONSORED ADS | $6.9M | 1.5% | 359,050 SH | New |
| DIANTHUS THERAPEUTICS INC | COM | $6.2M | 1.3%Prev: 1.3% | 150,000 SH | Increased+25,000 SH |
| DISC MEDICINE INC | COM | $5.9M | 1.3%Prev: 1.3% | 74,000 SH | Increased |
| ENLIVEN THERAPEUTICS INC | COM | $4.7M | 1.0%Prev: 1.4% | 308,141 SH | Decreased+57,303 SH |
| EYEPOINT INC | COM NEW | $14.3M | 3.1% | 780,000 SH | New |
| HARROW INC | COM | $345K | 0.1% | 7,031 SH | New |
| INSMED INC | COM PAR $.01 | $46.5M | 9.9%Prev: 12.6% | 267,000 SH | Decreased-59,400 SH |
| KYMERA THERAPEUTICS INC | COM | $10.8M | 2.3%Prev: 1.4% | 139,000 SH | Increased+46,408 SH |
| LIQUIDIA CORPORATION | COM NEW | $7.8M | 1.7%Prev: 2.4% | 227,000 SH | Decreased-173,000 SH |
| MIRUM PHARMACEUTICALS INC | COM | $23.6M | 5.1%Prev: 2.0% | 298,682 SH | Increased+194,420 SH |
| OCULAR THERAPEUTIX INC | COM | $5.9M | 1.3%Prev: 2.2% | 490,000 SH | Decreased-225,000 SH |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | $3.1M | 0.7%Prev: 0.3% | 1,132,815 SH | Increased+783,492 SH |
| PHARVARIS N V | COM | $15.1M | 3.2%Prev: 2.3% | 542,696 SH | Increased+197,315 SH |
| ROIVANT SCIENCES LTD | SHS | $177.2M | 37.9%Prev: 50.5% | 8,166,047 SH | Decreased-4,313,953 SH |
| SPYRE THERAPEUTICS INC | COM NEW | $4.9M | 1.1% | 150,000 SH | New |
| TERNS PHARMACEUTICALS INC | COM | $12.9M | 2.8% | 320,000 SH | New |
| XENON PHARMACEUTICALS INC | COM | $6.1M | 1.3% | 136,500 SH | New |
| 13F-HR |
| 0001819257-26-000005 |
| $645.5M |
| View |
| Aug 11, 2025 | Q2 2025 | 13F-HR | 0000950123-25-007478 | $277.4M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001819257-26-000003 | $563.6M | View |
| May 14, 2025 | Q1 2025 | 13F-HR | 0000950123-25-005195 | $241.7M | View |